Fig. 2

Population coverage analysis of selected T-cell epitopes across global and regional populations. The bar graph indicates the percentage coverage in the global population (84%) and specific regions, including England (91%), France (90%), Germany (89%), Europe (86%), South Africa (84%), Japan (84%), China (80%), Pakistan (78%), and Iran (75%). This analysis highlights the potential broad applicability of the designed MEV in diverse geographical and demographic populations.